Ocular Therapeutix (OCUL) FCF Margin (2014 - 2026)
Ocular Therapeutix's quarterly FCF Margin came in at 624.2% in Q1 2026, down 18857.0% year-on-year from N/an in Q1 2025, and down 78.82% quarter-over-quarter from 349.07% in Q4 2025.
Ocular Therapeutix has reported FCF Margin for 13 years, with the latest figure at 624.2% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 18857.0% year-over-year to 624.2%; the trailing twelve-month figure through Mar 2026 stood at 435.78% (down 18889.0% YoY), and the FY2025 full-year result was 396.64%, down 18510.0% from the prior year.
- FCF Margin for Q1 2026 stood at 624.2%, down from 349.07% in the prior quarter.
- The five-year high for FCF Margin was 52.99% in Q3 2023, with the low at 624.2% in Q1 2026.
- Average FCF Margin over 5 years is 237.55%, with a median of 163.3% recorded in 2023.
- Year-over-year, FCF Margin jumped 9343 bps in 2022 and tumbled 26430 bps in 2025.
- Tracing OCUL's FCF Margin over 5 years: stood at 143.49% in 2022, then increased by 21 bps to 113.79% in 2023, then sank by 103 bps to 231.09% in 2024, then tumbled by 51 bps to 349.07% in 2025, then tumbled by 79 bps to 624.2% in 2026.
- The last three FCF Margin figures came in at 624.2% (Q1 2026), 349.07% (Q4 2025), and 389.98% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -624.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -624.20% |
| Dec 31, 2025 | -349.07% |
| Sep 30, 2025 | -389.98% |
| Jun 30, 2025 | -419.67% |
| Mar 31, 2025 | -435.63% |
| Dec 31, 2024 | -231.09% |
| Sep 30, 2024 | -231.04% |
| Jun 30, 2024 | -155.37% |
| Mar 31, 2024 | -231.10% |
| Dec 31, 2023 | -113.79% |
| Sep 30, 2023 | -52.99% |
| Jun 30, 2023 | -163.30% |
| Mar 31, 2023 | -154.17% |
| Dec 31, 2022 | -143.49% |
| Sep 30, 2022 | -112.00% |
| Jun 30, 2022 | -88.42% |
| Mar 31, 2022 | -143.14% |
| Dec 31, 2021 | -128.24% |
| Sep 30, 2021 | -111.39% |
| Jun 30, 2021 | -171.14% |
| Mar 31, 2021 | -236.57% |
| Dec 31, 2020 | -85.26% |
| Sep 30, 2020 | -227.28% |
| Jun 30, 2020 | -950.99% |
| Mar 31, 2020 | -732.20% |
| Dec 31, 2019 | -851.82% |
| Sep 30, 2019 | -2,266.59% |
| Jun 30, 2019 | -3,111.23% |
| Mar 31, 2019 | -3,976.02% |
| Dec 31, 2018 | -2,458.93% |
| Sep 30, 2018 | -2,448.59% |
| Jun 30, 2018 | -1,842.75% |
| Mar 31, 2018 | -3,780.59% |
| Dec 31, 2017 | -2,178.03% |
| Sep 30, 2017 | -2,567.30% |
| Jun 30, 2017 | -2,453.42% |
| Mar 31, 2017 | -3,417.05% |
| Dec 31, 2016 | -1,622.70% |
| Sep 30, 2016 | -1,757.23% |
| Jun 30, 2016 | -2,240.59% |
| Mar 31, 2016 | -2,251.20% |
| Dec 31, 2015 | -2,311.93% |
| Sep 30, 2015 | -23,843.90% |
| Jun 30, 2015 | -2,048.58% |
| Mar 31, 2015 | -3,039.08% |
| Dec 31, 2014 | -1,139.60% |
| Sep 30, 2014 | -4,395.80% |
| Jun 30, 2014 | -4,435.05% |
| Mar 31, 2014 | -16,007.41% |